Holen Sie sich die Stockscreener-App
187.50
0.13%
-0.24
Handel nachbörslich:
187.50
Schlusskurs vom Vortag:
$187.74
Offen:
$185.28
24-Stunden-Volumen:
753.45K
Relative Volume:
1.09
Marktkapitalisierung:
$10.63B
Einnahmen:
$4.08B
Nettoeinkommen (Verlust:
$431.79M
KGV:
19.88
EPS:
9.43
Netto-Cashflow:
$486.92M
1W Leistung:
-15.04%
1M Leistung:
-5.19%
6M Leistung:
-15.39%
1J Leistung:
-0.81%
1-Tages-Spanne:
$183.58
$187.93
1-Wochen-Bereich:
$183.35
$221.60
52-Wochen-Spanne:
$176.48
$275.00
Charles River Laboratories International Inc Stock (CRL) Company Profile
Firmenname
Charles River Laboratories International Inc
Sektor
Branche
Telefon
781-222-6000
Adresse
251 BALLARDVALE ST, WILMINGTON, MA
Vergleichen Sie CRL mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
| CRL | 187.50 | 10.63B | 4.08B | 431.79M | 486.92M | 9.43 |
| TMO | 501.29 | 192.46B | 42.37B | 6.14B | 7.78B | 15.26 |
| DHR | 230.06 | 166.23B | 23.74B | 3.89B | 4.98B | 7.93 |
| A | 126.92 | 36.47B | 6.50B | 1.41B | 1.42B | 3.82 |
| IQV | 191.04 | 34.67B | 15.32B | 1.41B | 1.96B | 5.95 |
| IDXX | 419.83 | 34.38B | 3.84B | 866.24M | 792.60M | 9.80 |
Charles River Laboratories International Inc Stock (CRL) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-02-15 | Herabstufung | Guggenheim | Buy → Neutral |
| 2023-09-13 | Eingeleitet | TD Cowen | Market Perform |
| 2023-07-10 | Herabstufung | Citigroup | Buy → Neutral |
| 2023-02-23 | Hochstufung | Guggenheim | Neutral → Buy |
| 2023-01-12 | Herabstufung | Jefferies | Buy → Hold |
| 2022-09-30 | Hochstufung | Jefferies | Hold → Buy |
| 2022-08-25 | Eingeleitet | Credit Suisse | Outperform |
| 2022-08-04 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2022-05-24 | Eingeleitet | Guggenheim | Neutral |
| 2022-04-25 | Herabstufung | Jefferies | Buy → Hold |
| 2022-04-07 | Eingeleitet | Stephens | Overweight |
| 2022-02-17 | Bestätigt | BofA Securities | Buy |
| 2022-02-17 | Hochstufung | Citigroup | Neutral → Buy |
| 2022-02-17 | Bestätigt | Deutsche Bank | Buy |
| 2022-02-17 | Bestätigt | Morgan Stanley | Overweight |
| 2022-02-17 | Bestätigt | UBS | Buy |
| 2021-08-05 | Fortgesetzt | Credit Suisse | Neutral |
| 2020-12-16 | Herabstufung | Citigroup | Buy → Neutral |
| 2020-09-10 | Hochstufung | Jefferies | Hold → Buy |
| 2020-07-01 | Hochstufung | BofA Securities | Neutral → Buy |
| 2020-05-13 | Hochstufung | UBS | Neutral → Buy |
| 2020-04-21 | Herabstufung | Jefferies | Buy → Hold |
| 2020-03-27 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2020-03-02 | Eingeleitet | Deutsche Bank | Buy |
| 2020-02-18 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2020-01-10 | Hochstufung | Goldman | Neutral → Buy |
| 2020-01-08 | Eingeleitet | Wells Fargo | Overweight |
| 2020-01-07 | Eingeleitet | Citigroup | Buy |
| 2019-10-18 | Herabstufung | BofA/Merrill | Buy → Neutral |
| 2019-06-10 | Eingeleitet | SVB Leerink | Outperform |
| 2019-04-30 | Fortgesetzt | Evercore ISI | Outperform |
| 2018-12-14 | Eingeleitet | Deutsche Bank | Buy |
| 2018-10-09 | Eingeleitet | UBS | Neutral |
| 2018-08-23 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2018-07-17 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2018-06-15 | Hochstufung | KeyBanc Capital Mkts | Sector Weight → Overweight |
| 2018-02-14 | Hochstufung | SunTrust | Hold → Buy |
Alle ansehen
Charles River Laboratories International Inc Aktie (CRL) Neueste Nachrichten
Layoff Tracker: Gilead Sciences Will Lay Off 104 Employees at California HQ - BioSpace
Mawer Investment Management Ltd. Sells 32,693 Shares of Charles River Laboratories International, Inc. (NYSE:CRL) - MarketBeat
Charles River Laboratories International (NYSE:CRL) Rating Lowered to Underperform at CLSA - MarketBeat
Charles River Laboratories International, Inc. (NYSE:CRL) Shares Acquired by Sumitomo Mitsui Trust Group Inc. - MarketBeat
Mizuho Securities USA LLC Buys 92,895 Shares of Charles River Laboratories International, Inc. (NYSE:CRL) - MarketBeat
Charles River Laboratories International, Inc. (NYSE:CRL) Shares Sold by KBC Group NV - MarketBeat
Charles River Labs closes several locations, 1,300+ jobs cut in cost saving initiative - MassLive.com
Pharmaceutical Sterility Testing Market to Drive Revenue to USD 3.79 Billion by 2032 | CAGR 11.58% - GlobeNewswire Inc.
Charles River Laboratories International, Inc. (NYSE:CRL) Holdings Decreased by Victory Capital Management Inc. - MarketBeat
Entropy Technologies LP Reduces Position in Charles River Laboratories International, Inc. (NYSE:CRL) - MarketBeat
Entropy Technologies LP Trims Holdings in Charles River Laboratories International, Inc. (NYSE:CRL) - MarketBeat
Empower Advisory Group LLC Sells 3,497 Shares of Charles River Laboratories International, Inc. (NYSE:CRL) - MarketBeat
Charles River Labs to close Skokie office - Crain's Chicago Business
Charles River Laboratories To Present At UBS Global Healthcare Conference; Webcast At 1:15 PM ET - Nasdaq
Charles River Laboratories International, Inc. (NYSE:CRL) Shares Purchased by WCM Investment Management LLC - MarketBeat
Charles River Laboratories International, Inc. (NYSE:CRL) Position Lowered by Amalgamated Bank - MarketBeat
Genotoxicity Tests Market Trends Detailed Research and Projected Growth through 2032 - WICZ
Charles River Laboratories International (NYSE:CRL) Stock Price Expected to Rise, TD Cowen Analyst Says - MarketBeat
Charles River (CRL) International Revenue in Focus: Trends and Expectations - Yahoo Finance
Charles River Labs to Present Strategic Updates at UBS and Jefferies Healthcare Events | CRL Stock News - StockTitan
Shareholders Can't Ignore US$5.2m Of Sales By Charles River Laboratories International Insiders - Simply Wall St
William Blair Brokers Decrease Earnings Estimates for CRL - MarketBeat
Jensen Investment Management Inc. Decreases Stock Position in Charles River Laboratories International, Inc. (NYSE:CRL) - MarketBeat
Wellington Management Group LLP's Strategic Acquisition in Charles River Laboratories - GuruFocus.com
Charles River Laboratories International, Inc. (NYSE:CRL) Q3 2024 Earnings Call Transcript - Insider Monkey
Charles River Laboratories International Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags - Yahoo Finance
Earnings call: Charles River Laboratories reports Q3 2024 results - Investing.com
Evercore ISI Issues Positive Forecast for Charles River Laboratories International (NYSE:CRL) Stock Price - MarketBeat
CLSA Upgrades Charles River Laboratories International (NYSE:CRL) to Hold - MarketBeat
Charles River Labs Raises Profit Outlook After Strong Quarter - Finimize
Five things you need to know, and a lesson from presidential history - The Business Journals
Animal Model Market Generated Opportunities, Future Scope - openPR
Van ECK Associates Corp Cuts Stock Position in Charles River Laboratories International, Inc. (NYSE:CRL) - MarketBeat
Charles River Laboratories International Inc (CRL) Q3 2024 Earni - GuruFocus.com
Decoding Charles River Laboratories International Inc (CRL): A S - GuruFocus.com
Charles River Earnings: Headwinds From Reduced Client Spending; Positive Long-Term Outlook - Morningstar
Charles River Laboratories International Inc (CRL) Q3 2024 Earnings Call Highlights: Navigating ... - Yahoo Finance UK
Charles River Laboratories Announces Third-Quarter 2024 Results - citybiz
Decoding Charles River Laboratories International Inc (CRL): A Strategic SWOT Insight - Yahoo Finance
Charles River Laboratories Reports 2024 Q3 Financial Results - TipRanks
Charles River Laboratories Q3 2024 Earnings Preview - MSN
Charles River: Q3 Earnings Snapshot - The Washington Post
Charles River Laboratories International Inc (CRL) Stock Price U - GuruFocus.com
Massachusetts-based Charles River Labs cuts 1,300 workers, will close over a dozen sites - NBC Boston
Charles River Labs cuts 1,300 workers; will close more than a dozen sites - The Business Journals
Charles River's Q3 Earnings, Revenues Beat Estimates, Margins Fall - Yahoo Finance
Why Is Charles River Laboratories Stock Trading Higher On Wednesday?Charles River (NYSE:CRL) - Benzinga
Charles River (CRL) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates - Yahoo Finance
Charles River Laboratories International, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 28, 2024 - Marketscreener.com
Charles River Laboratories International (NYSE:CRL) Releases FY 2024 Earnings Guidance - MarketBeat
Charles River Laboratories International Q3 24 Earnings Conference Call At 9:30 AM ET - Nasdaq
Finanzdaten der Charles River Laboratories International Inc-Aktie (CRL)
Umsatz
Nettogewinn
Free Cashflow
ENV
5.04%
3.19%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):